跳至主要内容
临床试验/NCT01340287
NCT01340287已完成不适用

Effects of the Consumption of a Plant Sterols-enriched Dairy Fermented Product on Hypercholesterolemia Management in Hypercholesterolemic Adults

Danone Research1 个研究点 分布在 1 个国家目标入组 168 人开始时间: 2008年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
168
试验地点
1

研究概览

简要总结

The purpose of this study is to investigate the cholesterol lowering effect of a drinkable low fat fermented milk enriched with plant sterol after 3 and 6 weeks of daily consumption in midly hypercholesterolemic people not treated by statins.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male/female subject,
  • aged from 21 to 75 years,
  • BMI between 19 and 30 kg/m2,
  • LDL-cholesterol plasma level between 130 and 190 mg/dL without statin monotherapy,
  • stabilized hypercholesterolemia,
  • accepting to follow the dietary recommendations advisable for hypercholesterolemic patient (NCEP-ATP III guidelines),
  • used to consume dairy products,
  • effective contraceptive methods used for female subjects,
  • having given written consent to take part in the study

排除标准

  • subject with plasma triglycerides (TG) levels ≥ 350 mg/dL,
  • having experienced any cardiovascular event in the last 6 months,
  • taking any hypocholesterolemic treatment,
  • diabetic subject (type I and type II),
  • smoking strictly more than 10 cigarettes / day,
  • heavy alcohol intake (> 40 g / day for men ; > 30 g / day for women),
  • presenting known allergy or hypersensitivity to milk proteins,
  • known soy allergy,
  • refusing to stop the consumption of plant sterols-enriched products (other than the studied product),
  • receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters,
  • receiving a transplant and under immunosuppressor treatment,
  • currently involved in a clinical trial or in an exclusion period following participation in another clinical trial,
  • in a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject,
  • with any kind of disease likely to interfere with the evaluation of efficiency or safety of the product,
  • for female subject: pregnancy, breast feeding or intention to be pregnant during the study or subject likely to change her contraceptive method during the study

研究者

发起方
Danone Research
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验